Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study-Reference-Cited by-同舟云学术

Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study

Published:2016-11-30 Issue:11 Volume:11 Page:e0167036
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Hui,Li Lin,Gu Jian,Li Yu,Chen Xiaoli,Yang Dongzi

Funder

National Natural Science Foundation of China

Sun Yat-sen University

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Prevalence of polycystic ovary syndrome in women in China: a large community-based study;R Li;Human Reprod,2013

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;Fertil Steril,2004

3. National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome: Final Report. NIH: the Office of Disease Prevention and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; 2012.

4. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome;R Huang;Acta Obstet Gynecol Scand,2015

5. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype;E Lerchbaum;PLoS One,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease;Current Cardiology Reports;2024-04-03

2. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population;Scientific Reports;2023-06-24

3. Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome;Diagnostics;2023-06-14

4. Hyperandrogen-induced polyol pathway flux increase affects ovarian function in polycystic ovary syndrome via excessive oxidative stress;Life Sciences;2023-01

5. Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic;Gynecological Endocrinology;2022-08-21